Amgen (NASDAQ:AMGN), a biotechnology pioneer, discovers, develops, and delivers innovative human therapeutics. Our medicines help millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, we continue to advance science to serve patients.
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information about AstraZeneca in the U.S. or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. www.celgene.com
CuraScript Specialty Pharmacy is one of the nation’s leading providers of specialty medications and clinical care management. We are aligned with our health plan sponsor, physician and pharmaceutical company clients to deliver superior care to our patients and eliminate wasted health care dollars.
Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response.
MOSAIQ oncology information management solutions are backed by the full financial and technological resources of Elekta, serving the oncology community since 1972. In the information technology market, we bring a unique level of experience, stability and oncology knowledge to address our customers’ clinical workflow challenges. Elekta has earned the trust of a diverse and expanding base of customers who demand exceptional information solutions and efficient workflows. MOSAIQ is used in over 4,000 cancer centers—from practices with a single clinician to groups with over 100 physicians. www.elekta.com
Eviti, Inc. is a leading health information technology company delivering web-based decision-support services to improve the quality of cancer care and reduce its cost. eviti represents the culmination of almost a decade of experience providing oncology treatment intelligence, uniquely delivering value to all parties in the care process by ensuring quality care is prescribed from the start. www.eviti.com
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on developing and commercializing proprietary small molecule drugs for oncology and inflammation. Our lead product Jakafi™ (ruxolitinib), an oral JAK1 and JAK2 inhibitor, was recently approved by the FDA. For additional information on Jakafi, please go to www.Jakafi.com or visit www.incyte.com.
OncologyExpress is a division of Innovatix dedicated to helping oncologists make smart purchasing decisions while enhancing the delivery of care. Our membership-driven organization helps thousands of oncologists throughout the United States and Puerto Rico achieve substantial savings on their daily purchases. www.innovatix.com
Intrinsiq, LLC AmerisourceBergen
IntelliDose by IntrinsiQ automates every aspect of medical oncology and integrates with PM, EHR and HIS systems adding oncology-specific CPOE, e-prescribing, workflow, charge capture and business performance measurement. IntelliDose is improving the quality of care and delivering a proven ROI in hospitals and oncology practices throughout the U.S.
McKesson Specialty Health
Onmark Select Program, delivered through McKesson Specialty Health, offers community oncology practices proven, customizable services including distribution and GPO services, iKnowMed™ and Lynx® integrated technology, revenue cycle solutions, clinical tools, business resources and clinical trial support. Practices have the flexibility to choose products and commitment levels to meet their priorities. www.mckessonspecialtyhealth.com The US Oncology Network, supported by McKesson Specialty Health, is one of the nation’s largest networks of community-based oncology physicians dedicated to advancing cancer care in America. Like-minded physicians are united through The Network around a common vision of expanding patient access to high-quality, integrated cancer care in communities throughout the nation. www.usoncology.com
Millennium: The Takeda Oncology Company
Millennium: The Takeda Oncology Company combines the innovative science of a leading American biopharmaceutical company with the global assets - both intellectual and fiscal - of Japan's largest pharmaceutical company. Our mission is to deliver extraordinary medicines to patients with cancer worldwide through our science, innovation, and passion. We are focused exclusively in oncology to improve the treatment of cancer around the world. Our pipeline has more than 15 oncology investigational compounds that target a broad range of cancers.
Myriad Genetic Laboratories, Inc
Myriad Genetics is a healthcare company focused on the development and marketing of novel molecular diagnostic products. We are committed to improve patient healthcare through the commercialization of predictive medicine, personalized medicine, and prognostic medicine products.
At Novartis Oncology, our employees worldwide share a common mission: discover and develop innovative medicines to fight cancer. Headquartered in Florham Park, New Jersey, we are passionate about providing a broad range of new remedies and practical solutions that change the way patients live with cancer.
Omni Health Media/Cancer Connect.com
Omni Health Media, publisher of Women Magazine and CancerConnect.com an online community for cancer patients and care givers. CancerConnect.com offers a "private label" online community that can be completely branded for your cancer center, hospital, health system or physicians office. This allows members of the online community to communicate with their provider as well as other community members from around the country CancerConnect.com communities are HIPPA compliant as members manage their individual privacy controls. For more information email firstname.lastname@example.org or visit www.omnihealthmedia.com
Oncology Convergence, Inc.
Oncology Convergence (OCI) is a management organization that specializes in medical and radiation oncology revenue management. Oncology Convergence works with physician practices, hospitals, freestanding radiation treatment facilities and comprehensive cancer centers that may have challenges related to the revenue cycle process- including billing, revenue recovery, A/R, contracting or reimbursement. OCI also offers more traditional consulting and advisory services related to practice development, process improvement and EHR installation.
Oncology Supply/ ION Solutions Oncology Supply is the nation’s largest distributor of Chemotherapy drugs & Supplies, earning a respected name in the wholesale specialty arena with more than 30 years of experience. For the community-based oncology practice, Oncology Supply has become the first choice for reliability, stability, integrity and honesty. Bringing technology to the forefront, Oncology Supply’s Nucleus® cabinet offers support and solutions for your practice’s inventory management needs. Our goal is to deliver responsive and innovative solutions to help our business partners positively impact cancer patients’ lives. For more information, visit www.oncologysupply.com.
ION Solutions continues to fulfill its mission of serving as a truly diversified physician services organization by partnering with a variety of innovative companies. Drive Practice Growth with Nucleus Solutions….an integrated platform of practice improvement tools that boost efficiency, cost-effectiveness and accountability. ION Solutions is committed to helping practices deliver exceptional patient care & the services our valued partners provide can have a major effect on the success of your practice. Members are eligible for preferred pricing and rebate opportunities. Visit www.iononline.com & www.NucleusOncology.com for more information. ION Solutions and Oncology Supply work in tandem with several other sister companies to form the AmerisourceBergen Specialty Group, the specialty pharmaceutical branch of AmerisourceBergen Corporation.
OncoMed The Oncology Pharmacy
OncoMed, The Oncology Pharmacy, provides comprehensive, proven oncology pharmacy solutions to more than 1,600 oncologists and 35 payers through a growing national network of certified and JCAHO-accredited pharmacies. In addition to providing robust clinical management, compounding, and dispensing services that meet the highest professional standards for quality, safety, and timely and accurate treatment delivery, OncoMed provides critical financial, administrative, and compliance support for oncology and hematology physicians, cancer centers of excellence, cancer patients, pharmaceutical manufacturers, and health plans.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company’s website at www.onyx-pharm.com.
Outpatient Infusion Systems
The future of ambulatory infusion is here and available now…OIS Paperless. Our proprietary technology greatly reduces the time required to administer the Outpatient Infusion Systems ambulatory pump program, saving your pharmacy valuable time and streamlining processes. www.ois-inc.net
Prometheus Laboratories Inc
Prometheus Laboratories Inc. is committed to improving lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care. Prometheus applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and is applying these principles to oncology.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). www.sanofi.com
Cephalon Oncology is now Teva Oncology. The portfolio includes TREANDA (bendamustine HCl) for Injection, TRISENOX (arsenic trioxide) injection and a robust pipeline that includes multiple oncology compounds across cancer therapeutics and supportive care. The combined company will utilize complementary commercial, R&D, and operational capabilities to provide a broad spectrum of oncology products.
Varian Medical Systems
Varian Medical Systems is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company also supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices.